China’s CanSino Biologics Inc said on Sunday that its recently developed COVID-19 vaccine has been approved by the country’s drug regulator for emergency use as a booster, potentially benefiting its business. The inhaled version of Cansino’s adenovirus-vectored COVID-19 vaccine has obtained the green light from the National Medical Products Administration, the company said in a… Read More China approves CanSino’s inhaled coronavirus vaccine for emergency use
The U.S. Food and Drug Administration on Wednesday authorized updated COVID-19 booster shots from Pfizer/BioNTech and Moderna that target the dominant BA.4 and BA.5 Omicron subvariants, as the government prepares for a broad fall vaccination campaign that could begin within days. The new vaccines also include the original version of the virus targeted by all… Read More U.S. FDA approves coronavirus vaccines engineered for Omicron variant
Moderna sued Pfizer and its German partner BioNTech on Friday for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic. Pfizer shares fell nearly 1%, while BioNTech U.S.-listed shares were down about 1.5% and Moderna shares slipped 1.7%… Read More Moderna files lawsuit against Pfizer/BioNTech for patent infringement over coronavirus vaccine
Pfizer Inc and German partner BioNTech said on Monday they had sought U.S. authorization for a COVID-19 vaccine retooled to target the Omicron variant. The request to the Food and Drug Administration was for a so-called bivalent vaccine containing the dominant BA.4/BA.5 variants of the virus along with the original coronavirus strain. It is intended… Read More Pfizer seeks U.S. authorization for coronavirus vaccine engineered to tackle Omicron variant
Britain, the first country to approve a coronavirus vaccine in late 2020, has now also given the first green light to a variant-adapted shot that targets both the original and Omicron version of the virus. The UK medicines regulator (MHRA) gave the so-called bivalent vaccine made by U.S. drug company Moderna conditional approval as a… Read More Britain approves vaccine to tackle Omicron coronavirus variant
Moderna Inc said on Friday Swiss drugs regulator Swissmedic had authorized the use of its COVID-19 vaccine for children aged 6 to 11 years. The approval is for the vaccine’s two-dose series of 50 micro gram per dose, Moderna added.
South Korea plans to provide COVID-19 vaccines and other medical supplies to the North, President Yoon Suk-yeol’s office said on Friday, a day after the neighbouring country confirmed its first outbreak of coronavirus. “We will discuss detailed plans for assistance with North Korea,” Yoon’s spokesperson said in a statement.
Nigeria on Wednesday destroyed more than a million doses of expired AstraZeneca vaccines in a bid to assure a wary public that they have been taken out of circulation. The destruction came more than a week after health authorities said some COVID-19 doses donated by rich Western nations had a shelf life that left only… Read More Nigeria destroys over one million doses of donated AstraZeneca corona vaccine with short shelf life